Drug Information

Drug General Information
Drug ID
D04UFI
Former ID
DIB002063
Drug Name
ImMucin
Synonyms
MUC-1 peptide vaccine (cancer), Vaxil BioTherapeutics/Hadassah Medical
Drug Type
Vaccine
Indication Multiple myeloma [ICD9: 203; ICD10:C90] Phase 1/2 [523236]
Company
Hadassah Medical Organization
Target and Pathway
Target(s) Mucin 1 Target Info [533070]
WikiPathways Hematopoietic Stem Cell Differentiation
References
Ref 523236ClinicalTrials.gov (NCT01232712) A Study to Assess the Safety and Efficacy of MUC1 Peptide Vaccine and hGM-CSF in Patients With MUC1-positive Tumor Malignancies. U.S. National Institutes of Health.
Ref 533070Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients. Br J Haematol. 2015 Apr;169(1):44-56.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.